Circulating PCSK9 is associated with liver biomarkers and hepatic steatosis

Publication: Clinical Biochemistry

Paquette M, Gauthier D, Chamberland A, Prat A, De Lucia Rolfe E, Rasmussen J et al.

March 2020


Summary

The objective of this study is to investigate the association between circulating PCSK9 levels and the presence of hepatic steatosis, as well as with liver biomarkers in a cohort of healthy individuals.

View publication

© Copyright - NIHR Cambridge Biomedical Research Centre 2025